Michael R. Merson is Director at AspenBio Pharma, Inc. (APPY). They have made 3 open-market trades across 1 company since 2009, most recently 2012-06-29.
CIK 0001440213
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $7K since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APPY | 1,180 | $5K |
Shares reported on the most recent Form 4, priced at the 2012-07-03 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.